OTC Markets OTCPK - Delayed Quote USD

Novo Nordisk A/S (NONOF)

Compare
131.20 0.00 (0.00%)
At close: July 23 at 4:00 PM EDT
Loading Chart for NONOF
DELL
  • Previous Close 0.00
  • Open 133.00
  • Bid 129.35 x 41800
  • Ask 138.60 x 28000
  • Day's Range 133.00 - 133.00
  • 52 Week Range 75.50 - 149.55
  • Volume 100
  • Avg. Volume 57,196
  • Market Cap (intraday) 599.354B
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 45.09
  • EPS (TTM) 2.91
  • Earnings Date Aug 7, 2024
  • Forward Dividend & Yield 1.86 (1.42%)
  • Ex-Dividend Date Mar 22, 2024
  • 1y Target Est --

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

www.novonordisk.com

66,015

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NONOF

View More

Related Videos: NONOF

Performance Overview: NONOF

Trailing total returns as of 7/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NONOF
28.93%
OMX Copenhagen 25 Index
8.11%

1-Year Return

NONOF
59.21%
OMX Copenhagen 25 Index
6.85%

3-Year Return

NONOF
204.33%
OMX Copenhagen 25 Index
2.41%

5-Year Return

NONOF
473.33%
OMX Copenhagen 25 Index
73.71%

Compare To: NONOF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NONOF

View More

Valuation Measures

Annual
As of 7/23/2024
  • Market Cap

    599.35B

  • Enterprise Value

    601.93B

  • Trailing P/E

    45.11

  • Forward P/E

    38.31

  • PEG Ratio (5yr expected)

    2.29

  • Price/Sales (ttm)

    16.49

  • Price/Book (mrq)

    40.44

  • Enterprise Value/Revenue

    16.89

  • Enterprise Value/EBITDA

    33.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    36.55%

  • Return on Assets (ttm)

    25.24%

  • Return on Equity (ttm)

    99.87%

  • Revenue (ttm)

    244.24B

  • Net Income Avi to Common (ttm)

    89.28B

  • Diluted EPS (ttm)

    2.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.3B

  • Total Debt/Equity (mrq)

    27.22%

  • Levered Free Cash Flow (ttm)

    40.24B

Company Insights: NONOF

People Also Watch